Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran; Nadine Landolina; Pratibha Gaur; Tihana Lenac Rovis; Stipan Jonjic; Ofer Mandelboim; Bernhard B. Singer; Francesca Levi-Schaffer

doi:10.1038/s41417-023-00594-2

Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran
, Nadine Landolina
, Pratibha Gaur
, Tihana Lenac Rovis
, Stipan Jonjic
, Ofer Mandelboim
, Bernhard B. Singer
, Francesca Levi-Schaffer^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Abstract

In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

Original language	English
Pages (from-to)	926
Number of pages	1
Journal	Cancer Gene Therapy
Volume	30
Issue number	6
DOIs	https://doi.org/10.1038/s41417-023-00594-2
State	Published - Jun 2023

Bibliographical note

Publisher Copyright:
© 2023 The Author(s), under exclusive licence to Springer Nature America, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41417-023-00594-2

Cite this

Zaffran, I., Landolina, N., Gaur, P., Rovis, T. L., Jonjic, S., Mandelboim, O., Singer, B. B., & Levi-Schaffer, F. (2023). Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x). Cancer Gene Therapy, 30(6), 926. https://doi.org/10.1038/s41417-023-00594-2

@article{1a4fc2bac6ed46fdb297a63b72c02f18,

title = "Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)",

abstract = "In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.",

author = "Ilan Zaffran and Nadine Landolina and Pratibha Gaur and Rovis, \{Tihana Lenac\} and Stipan Jonjic and Ofer Mandelboim and Singer, \{Bernhard B.\} and Francesca Levi-Schaffer",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2023",

month = jun,

doi = "10.1038/s41417-023-00594-2",

language = "אנגלית",

volume = "30",

pages = "926",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "6",

}

Zaffran, I, Landolina, N, Gaur, P, Rovis, TL, Jonjic, S, Mandelboim, O, Singer, BB & Levi-Schaffer, F 2023, 'Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)', Cancer Gene Therapy, vol. 30, no. 6, pp. 926. https://doi.org/10.1038/s41417-023-00594-2

TY - JOUR

T1 - Correction to

T2 - Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

AU - Zaffran, Ilan

AU - Landolina, Nadine

AU - Gaur, Pratibha

AU - Rovis, Tihana Lenac

AU - Jonjic, Stipan

AU - Mandelboim, Ofer

AU - Singer, Bernhard B.

AU - Levi-Schaffer, Francesca

PY - 2023/6

Y1 - 2023/6

N2 - In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

AB - In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85147375658

U2 - 10.1038/s41417-023-00594-2

DO - 10.1038/s41417-023-00594-2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36732550

AN - SCOPUS:85147375658

SN - 0929-1903

VL - 30

SP - 926

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 6

ER -

Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this